IL161308A0 - Alkyl ether derivatives or their salts - Google Patents
Alkyl ether derivatives or their saltsInfo
- Publication number
- IL161308A0 IL161308A0 IL16130802A IL16130802A IL161308A0 IL 161308 A0 IL161308 A0 IL 161308A0 IL 16130802 A IL16130802 A IL 16130802A IL 16130802 A IL16130802 A IL 16130802A IL 161308 A0 IL161308 A0 IL 161308A0
- Authority
- IL
- Israel
- Prior art keywords
- alkyl ether
- ether derivatives
- salts
- new
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001321381 | 2001-10-19 | ||
| PCT/JP2002/010827 WO2003035647A1 (fr) | 2001-10-19 | 2002-10-18 | Derives ou sels d'ether d'alkyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161308A0 true IL161308A0 (en) | 2004-09-27 |
Family
ID=19138603
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16130802A IL161308A0 (en) | 2001-10-19 | 2002-10-18 | Alkyl ether derivatives or their salts |
| IL161308A IL161308A (en) | 2001-10-19 | 2004-04-07 | Derivatives of ether alkyl or their salts, their preparation and pharmaceutical compounds containing them |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL161308A IL161308A (en) | 2001-10-19 | 2004-04-07 | Derivatives of ether alkyl or their salts, their preparation and pharmaceutical compounds containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US7087594B2 (zh) |
| EP (1) | EP1437353B1 (zh) |
| JP (1) | JP4398247B2 (zh) |
| KR (1) | KR100956990B1 (zh) |
| CN (2) | CN100500662C (zh) |
| AT (1) | ATE364604T1 (zh) |
| AU (1) | AU2002344107B2 (zh) |
| BR (1) | BRPI0213393B8 (zh) |
| CA (1) | CA2464358C (zh) |
| CY (1) | CY1106714T1 (zh) |
| DE (1) | DE60220694T2 (zh) |
| DK (1) | DK1437353T3 (zh) |
| ES (1) | ES2287324T3 (zh) |
| HU (1) | HU230407B1 (zh) |
| IL (2) | IL161308A0 (zh) |
| MX (1) | MXPA04003541A (zh) |
| NO (1) | NO325780B1 (zh) |
| NZ (1) | NZ532328A (zh) |
| PL (2) | PL215264B1 (zh) |
| PT (1) | PT1437353E (zh) |
| RO (1) | RO122203B1 (zh) |
| WO (1) | WO2003035647A1 (zh) |
| ZA (1) | ZA200402806B (zh) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1437353T3 (da) * | 2001-10-19 | 2007-08-06 | Toyama Chemical Co Ltd | Alkyletherderivater eller deres salte |
| DK2389937T3 (en) * | 2002-06-14 | 2018-11-12 | Toyama Chemical Co Ltd | Medical composition to improve brain function |
| US20060205709A1 (en) * | 2003-04-17 | 2006-09-14 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| AU2011204959B2 (en) * | 2005-03-28 | 2012-04-12 | Toyama Chemical Co., Ltd. | Process for production of 1-(3-(2-(1-benzothiophen-5-YL)- ethoxy)propyl)azetidin-3-ol or salts thereof |
| EP1864978A4 (en) * | 2005-03-28 | 2009-07-01 | Toyama Chemical Co Ltd | PROCESS FOR PRODUCING 1- (3- (2- (1-BENZOTHIOPHEN-5-YL) -ETHOXY) PROPYL) AZETIDIN-3-OL OR ITS SALTS |
| JP4902247B2 (ja) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | ２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体 |
| JP2006328058A (ja) * | 2005-04-27 | 2006-12-07 | Toyama Chem Co Ltd | ２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体 |
| US20090093453A1 (en) * | 2006-04-26 | 2009-04-09 | Toyama Chemical Co., Ltd | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| US8119625B2 (en) | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| DK2048145T3 (da) * | 2006-08-04 | 2011-04-04 | Toyama Chemical Co Ltd | Forstærker af aktiviteten af proteinkinase C indeholdende alkyletherderivat eller et salt deraf |
| MX2010012787A (es) * | 2008-05-28 | 2011-02-24 | Toyama Chemical Co Ltd | Nuevo derivado de oxido de benzotiofeno y sal del mismo. |
| CA2865380C (en) | 2012-02-22 | 2019-10-29 | Toyama Chemical Co., Ltd. | Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof |
| CN106061478B (zh) | 2014-01-31 | 2019-04-30 | 富士胶片富山化学株式会社 | 含有烷基醚衍生物或其盐的神经损伤后的康复效果促进剂 |
| JP6761413B2 (ja) * | 2015-06-11 | 2020-09-23 | 富士フイルム富山化学株式会社 | シグマ受容体結合剤 |
| CN108366989B (zh) | 2015-12-25 | 2020-11-03 | 富士胶片富山化学株式会社 | 含有1-(3-(2-(1-苯并噻吩-5-基-)乙氧基)丙基)氮杂环丁-3-醇或其盐的片剂 |
| JP7057287B2 (ja) | 2016-12-28 | 2022-04-19 | 富士フイルム富山化学株式会社 | 医薬組成物 |
| JP7057286B2 (ja) | 2016-12-28 | 2022-04-19 | 富士フイルム富山化学株式会社 | 医薬組成物 |
| WO2018124281A1 (ja) | 2016-12-28 | 2018-07-05 | 富山化学工業株式会社 | 外用組成物 |
| US11234962B2 (en) | 2016-12-28 | 2022-02-01 | Fujifilm Toyama Chemical Co., Ltd. | Pharmaceutical composition and method of manufacturing the same |
| SG11201911519UA (en) | 2017-06-02 | 2020-01-30 | Fujifilm Toyama Chemical Co Ltd | AGENT FOR REDUCING AMOUNT OF AMYLOID ß PROTEIN |
| US11660287B2 (en) | 2017-06-02 | 2023-05-30 | Fujifilm Toyama Chemical Co., Ltd. | Agent for preventing or treating spinocerebellar ataxia |
| AU2018277982B2 (en) | 2017-06-02 | 2021-04-08 | Fujifilm Toyama Chemical Co., Ltd. | Agent for preventing or treating tauopathy |
| JPWO2018221728A1 (ja) | 2017-06-02 | 2020-04-02 | 富士フイルム富山化学株式会社 | アルツハイマー型認知症予防または治療剤 |
| JP7282028B2 (ja) | 2017-06-02 | 2023-05-26 | 富士フイルム富山化学株式会社 | 脳萎縮予防または治療剤 |
| US11548878B2 (en) | 2017-10-30 | 2023-01-10 | Fujifilm Toyama Chemical Co., Ltd. | Emopamil binding protein binding agent and use thereof |
| CN114853619B (zh) * | 2022-05-19 | 2024-05-10 | 神隆医药（常熟）有限公司 | 一种适于工业化生产的n-甲基酪胺盐酸盐的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01156973A (ja) | 1987-09-04 | 1989-06-20 | Tanabe Seiyaku Co Ltd | ベンゾフラン誘導体 |
| JP2887492B2 (ja) | 1990-02-05 | 1999-04-26 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| JP3044055B2 (ja) | 1990-08-09 | 2000-05-22 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| DK74693D0 (da) | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| JP3232830B2 (ja) | 1993-11-30 | 2001-11-26 | 三菱電機株式会社 | フレキシブルディスク装置のキャリッジ機構 |
| JPH08268883A (ja) | 1994-10-25 | 1996-10-15 | Toyama Chem Co Ltd | １−フェニル−１，２−エタンジオール誘導体またはそ の塩を含有する神経成長因子の作用増強剤 |
| WO1996012717A1 (fr) * | 1994-10-25 | 1996-05-02 | Toyama Chemical Co., Ltd. | Potentialisateur de l'activite du facteur de croissance nerveuse contenant un derive de 1,2-ethanediol ou un sel de celui-ci |
| AU710984B2 (en) | 1995-08-11 | 1999-10-07 | Pfizer Inc. | (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin -1-yl)-1-propanolmethanesulfonate trihydrate |
| AU7001796A (en) | 1995-09-22 | 1997-04-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and medicinal use thereof |
| DE19605610A1 (de) | 1996-02-15 | 1997-08-21 | Hoechst Ag | Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| AU1672597A (en) | 1996-02-20 | 1997-09-10 | Toyama Chemical Co. Ltd. | Cerebral function ameliorant containing 1,2-ethanediol derivatives or salts thereof |
| JP4549452B2 (ja) | 1997-12-12 | 2010-09-22 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤 |
| WO1999031056A1 (fr) * | 1997-12-12 | 1999-06-24 | Toyama Chemical Co., Ltd. | Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant |
| KR100641352B1 (ko) | 1999-06-11 | 2006-11-02 | 토야마 케미칼 컴퍼니 리미티드 | Ｎ-알콕시알킬-ｎ,ｎ-디알킬아민 유도체 또는 그 염, 및이를 함유하는 신경퇴행성질환 치료제 |
| DK1437353T3 (da) | 2001-10-19 | 2007-08-06 | Toyama Chemical Co Ltd | Alkyletherderivater eller deres salte |
| DK2389937T3 (en) | 2002-06-14 | 2018-11-12 | Toyama Chemical Co Ltd | Medical composition to improve brain function |
| US20060205709A1 (en) | 2003-04-17 | 2006-09-14 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| EP1864978A4 (en) | 2005-03-28 | 2009-07-01 | Toyama Chemical Co Ltd | PROCESS FOR PRODUCING 1- (3- (2- (1-BENZOTHIOPHEN-5-YL) -ETHOXY) PROPYL) AZETIDIN-3-OL OR ITS SALTS |
| US20090093453A1 (en) | 2006-04-26 | 2009-04-09 | Toyama Chemical Co., Ltd | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| US8119625B2 (en) | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| DK2048145T3 (da) | 2006-08-04 | 2011-04-04 | Toyama Chemical Co Ltd | Forstærker af aktiviteten af proteinkinase C indeholdende alkyletherderivat eller et salt deraf |
| MX2010012787A (es) | 2008-05-28 | 2011-02-24 | Toyama Chemical Co Ltd | Nuevo derivado de oxido de benzotiofeno y sal del mismo. |
-
2002
- 2002-10-18 DK DK02777882T patent/DK1437353T3/da active
- 2002-10-18 MX MXPA04003541A patent/MXPA04003541A/es active IP Right Grant
- 2002-10-18 RO ROA200400354A patent/RO122203B1/ro unknown
- 2002-10-18 US US10/492,774 patent/US7087594B2/en not_active Ceased
- 2002-10-18 EP EP02777882A patent/EP1437353B1/en not_active Expired - Lifetime
- 2002-10-18 IL IL16130802A patent/IL161308A0/xx unknown
- 2002-10-18 ES ES02777882T patent/ES2287324T3/es not_active Expired - Lifetime
- 2002-10-18 CN CNB028206452A patent/CN100500662C/zh not_active Expired - Lifetime
- 2002-10-18 US US13/327,152 patent/USRE43676E1/en not_active Expired - Lifetime
- 2002-10-18 JP JP2003538163A patent/JP4398247B2/ja not_active Expired - Lifetime
- 2002-10-18 WO PCT/JP2002/010827 patent/WO2003035647A1/ja active IP Right Grant
- 2002-10-18 BR BRPI0213393A patent/BRPI0213393B8/pt not_active IP Right Cessation
- 2002-10-18 KR KR1020047005687A patent/KR100956990B1/ko active IP Right Grant
- 2002-10-18 CN CN2009102038534A patent/CN101643470B/zh not_active Expired - Lifetime
- 2002-10-18 PL PL369601A patent/PL215264B1/pl unknown
- 2002-10-18 PL PL402986A patent/PL217872B1/pl unknown
- 2002-10-18 AU AU2002344107A patent/AU2002344107B2/en not_active Expired
- 2002-10-18 DE DE60220694T patent/DE60220694T2/de not_active Expired - Lifetime
- 2002-10-18 PT PT02777882T patent/PT1437353E/pt unknown
- 2002-10-18 CA CA2464358A patent/CA2464358C/en not_active Expired - Lifetime
- 2002-10-18 NZ NZ532328A patent/NZ532328A/en not_active IP Right Cessation
- 2002-10-18 HU HU0500017A patent/HU230407B1/hu unknown
- 2002-10-18 AT AT02777882T patent/ATE364604T1/de active
-
2004
- 2004-04-07 IL IL161308A patent/IL161308A/en active IP Right Grant
- 2004-04-13 ZA ZA2004/02806A patent/ZA200402806B/en unknown
- 2004-04-15 NO NO20041531A patent/NO325780B1/no not_active IP Right Cessation
-
2006
- 2006-05-03 US US11/416,321 patent/US7468443B2/en not_active Expired - Lifetime
-
2007
- 2007-07-09 CY CY20071100909T patent/CY1106714T1/el unknown
-
2008
- 2008-10-17 US US12/253,379 patent/US8129535B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161308A0 (en) | Alkyl ether derivatives or their salts | |
| ES2182852T3 (es) | Derivados de prolinamida. | |
| SG11201804100UA (en) | Pharmaceutical composition comprising a potent inhibitor of urat1 | |
| MY133473A (en) | Haterocyclic glycyl beta-alanine derivatives. | |
| CY2097B1 (en) | 9-Deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and 8a-positions | |
| WO2002044192A1 (fr) | Derives de glucopyranosyloxybenzylbenzene, compositions medicinales contenant ces derives et produits intermediaires obtenus lors de l'elaboration de ces compositions | |
| TNSN05165A1 (fr) | Derives de pyrrolopyrimidine | |
| ATE312105T1 (de) | Camptothecinanaloge, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen | |
| IL150565A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| WO2001096334A3 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
| BR9910467A (pt) | Composto derivado de amida, processo para a preparação do mesmo, composição farmacêutica, e, uso de um composto derivado de amida | |
| MXPA02010405A (es) | Derivados de aminocarboxialquilo novedosos de acido barbiturico. | |
| ATE346042T1 (de) | Zyklische aminverbindungen als ccr5-rezeptor antagonisten | |
| FI963885A (fi) | Pyrimidiini- tai triatsiinikarboksyylihappojohdannaiset käytettäväksi lääkaineina | |
| HK1019334A1 (en) | 2-(arylphenyl) amino-imidazoline derivatives | |
| DE60123827D1 (en) | 1-methylcarbapenemderivate | |
| WO2004091633A8 (en) | Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof | |
| AU2408602A (en) | Indole derivatives and use thereof in medicines | |
| AU4842297A (en) | New N-benzylpiperazine compounds, process for their preparation and the pharmaceutical compositions which contain them | |
| BR9611572A (pt) | Produção de um sal de ácido clavulânico | |
| AU2003236180A1 (en) | Hydroxymorpholinone derivative and medicinal use thereof | |
| NO961657L (no) | Dibenz[b,eÅoksepinderivater, fremgangsmåte for fremstilling samt legemiddel inneholdende slike | |
| BR9810031A (pt) | Derivados de ácido pirrolidina carboxìlico como antagonistas á endotelina | |
| AU2134995A (en) | 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them | |
| CA2259218A1 (en) | Tetrahydrobenzindole compound |